Shypd.aiThe largest open index of AI tools
Algorae Pharmaceuticals (ASX: 1AI) is a pharmaceutical company that leverages AI for drug discovery and development. Its AlgoraeOS platform accelerates the development of long-term proprietary pipelines.
Trending
About
Algorae Pharmaceuticals (ASX: 1AI) is an Australian pharmaceutical company operating at the intersection of commercial supply and R&D. The company has two main divisions: AlgoraeRx and AlgoraeOS. AlgoraeRx focuses on sourcing and supplying generic and specialty medicines to the Australian and New Zealand markets through partnerships with global manufacturers. AlgoraeOS is their proprietary AI-powered drug discovery platform, built in collaboration with UNSW AI Institute and CSIRO Data 61, and independently validated by the Peter MacCallum Cancer Centre. This platform generates high-confidence drug-combination candidates for licensing and co-development, providing a continuously developing pipeline of novel programs. Algorae Pharmaceuticals aims to address medicine supply problems in Australia while developing innovative pharmaceutical solutions through AI.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check algoraepharma.com for current pricing.
FAQs
Trending
